Management of Hypertension in the Early Postpartum: a Randomized Controlled Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

Also called NCT04835233

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 180 participants (enrolled count) (from the registry)
Sponsor
Federal University of Paraíba (from the registry)
Registry
  • NCT NCT04835233
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04835233. Randomized; double masking; primary purpose treatment. Start 2021-05-01 (actual); primary completion 2022-12-16 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Management of Hypertension in the Early Postpartum: a Randomized Controlled Trial
Condition
Pregnancy-Induced Hypertension in Postpartum
Condition
Postpartum Pre-Eclampsia
Condition
Hypertension
Intervention (Drug)
Methyldopa 250 MG
Lead sponsor
Federal University of Paraíba (class: other)

Record details

Record id
cardio:ct-nct04835233
Content hash
7e746e46d7cc08abf7aece95f77a4ba7af9b4fc2e8730e9afec75ce9a043c033